• ADDvise Group AB (publ) (\"ADDvise\") has entered into an agreement to
acquire LabRum AB (\"LabRum\") with the planned admission on March 1st,
2016 (the \"Acquisition\").
• The acquisition also includes the shares in the subsidiaries LabRum AS
(100 percent), LabRum Klimat Oy (80 percent) and Kinda Fastighets AB (20
percent), all together (\"LabRum\").
• The purchase price amounts to 34.5 million SEK, with a possible
earn-out estimated to 11.5 million SEK.
• The Fiscal year 2014/2015 LabRum had a turnover of 72.5 million SEK
and generated an EBITDA of 7.4 million SEK.
• LabRum is one of Sweden\'s leading companies within laboratory
furniture, safety ventilation and laboratory equipment for both the
public and private sector.
• ADDvise and LabRum’s businesses complement each other well and a
number of positive synergies are expected from the acquisition.
Motives for the acquisition The acquisition of LabRum is another step in
the growth strategy adopted by the Board of ADDvise in early 2010.
LabRum contributes to a significant increase in ADDvise turnover and
operating profit. The acquisition is strategically important for the
business area Lab and will expand the range of products, strengthen the
competence in laboratory furniture, safety ventilation and laboratory
equipment as well as strengthening its presence in the Nordic market.
The acquisition creates Scandinavia’s leading group in laboratory
furniture and large industrial as well as financial synergies are
expected to be achieved.
Short about LabRum LabRum is one of the oldest companies within
laboratory furniture, safety ventilation and laboratory equipment. The
customers include both private companies and the public sector in the
Nordic region. Some of the customers are the Karolinska Institute, the
Swedish Police Authority, a number of universities and Bombardier
Transportation. LabRum currently has about 20 employees. The Fiscal year
2014/2015 LabRum had a turnover of 72.5 million SEK and generated an
EBITDA of 7.4 million SEK.
Pro forma If LabRum is consolidated on pro forma basis from October 1st,
2014 - September 30th, 2015, ADDvise pro forma turnover would amount to
224.3 (151.8) MSEK with an EBITDA of 14.7 (7.3) MSEK. This represents an
increase of 48 percent in turnover and 100 percent in EBITDA1.
Total consideration The total purchase price of approximately 46.0
million SEK will be distributed as follows:
• 34.5 million SEK is paid on the admission date
• Approximately 11.5 million SEK is paid in earn-out consideration
• The earn-out consideration is calculated as 116 percent of LabRum’s
reported EBITDA for the period May 1st, 2015 - April 30th, 2016
Admission is planned for March 1st, 2016.
Advisor Mangold Fondkommission AB is financial advisor to ADDvise in
connection with the acquisition and Baker & McKenzie KB is the legal
advisor.
For further information, please contact:
Rikard Akhtarzand, CEO, +46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
www.addvisegroup.com
--------------------------------------------------
(1) Since ADDvise and LabRum have different Fiscal years the pro forma
is calculated for the period 2015-05-01 - 2015-04-30 for LabRum and for
the period 2014-10-01 - 2015-09-30 for ADDvise.
About ADDvise Group AB
ADDvise Group AB (publ) is an expansive group which through its
subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise
Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical
Tables Inc offers comprehensive solutions in the form of products and
services to healthcare and research facilities. ADDvise Group\'s
customers are located in both the private and public sectors. The
Company\'s share is listed on First North Premier and Mangold
Fondkommission AB, +46 8-503015 50, is the company\'s Certified Adviser
and liquidity provider.
